Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT02932956
Title Glypican 3-specific Chimeric Antigen Receptor Expressed in T Cells for Patients With Pediatric Solid Tumors (GAP)
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Baylor College of Medicine

liver cancer

Advanced Solid Tumor


Cyclophosphamide + Fludarabine

Anti-GPC3-scFvGC33-CAR autologous T Lymphocytes

Age Groups: adult | child
Covered Countries USA

No variant requirements are available.